isoxazoles has been researched along with Uterine Cervical Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Altwerger, G; Andikyan, V; Azodi, M; Bellone, S; Bonazzoli, E; Gnutti, B; Guglielmi, A; Han, C; Huang, GS; Manara, P; Menderes, G; Nagarkatti, N; Pelligra, S; Ratner, E; Santin, AD; Schwartz, PE; Silasi, DA; Tymon-Rosario, J; Zammataro, L; Zeybek, B | 1 |
Du, J; Lou, G; Luan, J; Ma, W; Wang, K | 1 |
Araki, K; Kamide, D; Shiotani, A; Shiozawa, S; Tanaka, S; Tanaka, Y; Tomifuji, M; Yamashita, T | 1 |
Hedley, DW; Ruoso, P | 1 |
1 trial(s) available for isoxazoles and Uterine Cervical Neoplasms
Article | Year |
---|---|
Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer.
Topics: Adult; Aged; Analgesics; Cytokines; Female; Hospitalization; Humans; Isoxazoles; Laparoscopy; Middle Aged; Neoplasm Staging; Pain Measurement; Pain, Postoperative; RNA, Messenger; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Uterine Cervical Neoplasms | 2015 |
3 other study(ies) available for isoxazoles and Uterine Cervical Neoplasms
Article | Year |
---|---|
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Topics: Adult; Aged; Animals; Cell Line, Tumor; Female; Humans; Imidazoles; In Situ Hybridization, Fluorescence; Isoxazoles; Mice; Middle Aged; Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays; Young Adult | 2020 |
Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model.
Topics: Animals; Benzophenones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Transcription Factor AP-1; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cysteine; Enzyme Inhibitors; Female; gamma-Glutamyltransferase; Humans; Isoxazoles; Mice; Mice, SCID; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2004 |